LSBCF (LakeShore Biopharma Co) Stock Based Compensation: $0.00 Mil (TTM As of Mar. 2025)


What is LakeShore Biopharma Co Stock Based Compensation?

LakeShore Biopharma Co LSBCF Stock Based Compensation is $0.00 Mil as of Mar. 2025.

LakeShore Biopharma Co's Stock Based Compensation for the six months ended in Mar. 2025 was $0.00 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2025 was $0.00 Mil.

LakeShore Biopharma Co Stock Based Compensation Related Terms

LakeShore Biopharma Co Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for LakeShore Biopharma Co's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LakeShore Biopharma Co Stock Based Compensation Chart

LakeShore Biopharma Co Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25
Stock Based Compensation
11.79 1.22 0.51 1.36 1.87

LakeShore Biopharma Co Semi-Annual Data
Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only 0.52 0.00 0.00 0.00 0.00

LakeShore Biopharma Co Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.00 Mil.

What does a Stock Based Compensation of $0.00 Mil mean?
LakeShore Biopharma Co (LSBCF) has a Stock Based Compensation of $0.00 Mil as of Mar. 2025. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for LakeShore Biopharma Co and its competitors.
Is LakeShore Biopharma Co's Stock Based Compensation too high?
LakeShore Biopharma Co's current Stock Based Compensation is $0.00 Mil.
How does LakeShore Biopharma Co's Stock Based Compensation compare to ACUT and PPCB?
LakeShore Biopharma Co's Stock Based Compensation of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Biotechnology company?
A good Stock Based Compensation depends on the Biotechnology industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for LakeShore Biopharma Co and its competitors. LakeShore Biopharma Co's current Stock Based Compensation is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LakeShore Biopharma Co stock overvalued right now?
LakeShore Biopharma Co (LSBCF) has a current Stock Based Compensation of $0.00 Mil. The current Stock Based Compensation is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For LakeShore Biopharma Co (LSBCF), the current Stock Based Compensation is $0.00 Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

LakeShore Biopharma Co Business Description

Address 38 Yongda Road, Building No. 2, Daxing Biomedical Industry Park, Daxing District, Beijing, CHN, 102629
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.